Covid-19 roundup: Mer­ck­'s pill sees heavy use; Mod­er­na faces off against Pfiz­er in vac­cine race for youngest kids

Mer­ck’s new Covid-19 pill mol­nupi­ravir bare­ly cleared an FDA ad­vi­so­ry com­mit­tee vote (13-10) on the way to its EUA.

And al­though the FDA and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.